Novo Nordisk stock gains as it reports better-than-expected fourth-quarter 2024 results driven by strong sales of Diabetes ...

It is taken once a day, usually at bedtime. But it cannot replace the need for fast-acting insulins taken at mealtimes. They must still be taken - but, thanks to Lantus, there should be no ...

high GI foods can force the body to try to produce a surge of insulin to counteract the fast-acting carbohydrates and a ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind schedule ...

In the meantime, Novo Nordisk has responded to the threat from the cut-price fast and long-acting insulins with newer insulins that aim to improve on the performance of the established rivals.

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

The National Institute for Nephrology Dialysis and Transplantation (NINDT) has planned a series of events to mark this ...

LUCY Letby’s conviction risks being thrown wide open after medical experts deemed evidence used to convict her “unsafe”. Last ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...